Patient info Search Menu

Lemsip Cough for Mucus Cough & Catarrh 100 mg / 2.5 mg / 5 ml oral solution, Adult Meltus Chesty Coughs sugar & Colour free – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
General sale (GSL)
Medicine strength:
100 mg / 2.5 mg / 5 ml
Contains active substances:

Patient leaflet - Lemsip Cough for Mucus Cough & Catarrh 100 mg / 2.5 mg / 5 ml oral solution, Adult Meltus Chesty Coughs sugar & Colour free

1. What Lemsip Cough for Mucus Cough & Catarrh 100mg/2.5mg/5ml Oral Solution is and what it is used for

For the symptomatic relief of acute coughs and catarrh associated with influenza, colds and mild throat infections.

Each 5ml contains 100mg of the active ingredient guaifenesin and 2.5mg of the active ingredient Cetylpyridinium chloride.

Guaifenesin helps loosen the mucous (phlegm) from the lungs to help make it easier to cough up, while the cetylpyridinium chloride is an antiseptic which acts against the cause of throat infections.

2. Before taking Lemsip Cough for Mucus Cough & Catarrh 100mg/2.5mg/5ml Oral Solution

Do not take…

  • If you are allergic to any of the ingredients in this product. See ‘What this solution contains’ for the full list of ingredients.
  • Stop use if your cough lasts for more than 5 days, comes back, or is accompanied by a fever, rash or persistent headache.
  • This medicine with any other cough and cold medication.

Take special care…

  • Speak to your doctor or pharmacist if you are pregnant or breast feeding.

  • Speak to your doctor if you suffer from a chronic cough, if you have asthma or are suffering from an acute asthma attack.

Important information about some of the ingredients…

  • This product contains sorbitol. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctors before taking this medicinal product.
  • This product contains 9.0% v/v of ethanol, i.e. each 5ml dose can contains up to 0.364mg of alcohol, equivalent to 9ml of beer, or 3.75ml of wine. This can be harmful for those suffering from alcoholism. It should also be taken into account in pregnant or breast feeding women, children and high risk groups such as patients with liver disease or epilepsy.
  • If you have taken some of this medicine and are to undergo a urine test, tell your doctor prior to the test as guaifenesin may interfere with the results.

3. How to take Lemsip Cough for Mucus Cough & Catarrh 100mg/2.5mg/5ml Oral Solution Adults and children 12 years and over:

  • One or two 5ml spoonfuls.
  • To be taken every 3 or 4 hours.

Children under 12 years:

  • Not recommended for children under 12 years.

If you take too much of this solution…

If you take more of the solution than you should, speak to your doctor or pharmacist immediately.

4. Possible side effects

As with all medicines this solution can have side effects in some people.

  • Stomach discomfort has been reported.
  • Nausea, vomiting and hypersensitivity reactions.

If you feel you are reacting badly to this medicine in any way, or notice any other side effects not listed in this leaflet, please tell your doctor or pharmacist.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard

By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Lemsip Cough for Mucus Cough & Catarrh 100mg/2.5mg/5ml Oral Solution

  • Keep out of the sight and reach of children.
  • Do not store above 25°C.
  • Do not refrigerate or freeze.
  • Do not use after the expiry date shown on the label and carton.
  • If you find that you still have this medicine after its expiry date, return it to your local pharmacist who will dispose of it promptly.

6. What this solution contains

It also contains purified water, glycerol, ethanol, levomenthol, liquid sorbitol non-crystallising (E420), saccharin sodium, sodium cyclamate, povidone, custard flavour, raspberry flavour and blackberry flavour.

Lemsip Cough for Mucus Cough & Catarrh 100mg/2.5mg/5ml Oral Solution is a clear pale straw coloured solution with characteristic odour and flavour, for oral administration, in cartoned amber glass bottle of 100ml.

Marketing Authorisation Holder: Reckitt Benckiser Healthcare (UK) Limited, Slough, SL1 3UH, UK Date of Revision: March 2019

PL 00063/0760

Manufactured and Distributed by: Reckitt Benckiser Healthcare (UK) Limited, Dansom Lane, Hull, HU8 7DS, UK.

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk)

Last revision stated in the text: March 2019

What the sections and the side effect frequencies mean: How to read a patient leaflet

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Lemsip Cough for Mucus Cough & Catarrh 100 mg / 2.5 mg / 5 ml oral solution, Adult Meltus Chesty Coughs sugar & Colour free

What these facts mean

Prescription needed?? No, general sale list medicine (GSL) – also sold outside pharmacies
Active substances? Cetylpyridinium, Guaifenesin
Strength? 100 mg / 2.5 mg / 5 ml
Pharmaceutical form? Oral solution
How is it taken? Oral
Pack sizes 180 ml
Is it available?? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC)?
  1. R Respiratory system drugs
    1. R05 Cough and cold preparations
      1. R05C Expectorants, excl. combinations with cough suppressants
        1. R05CA Expectorants
          1. R05CA10 expectorant combinations excluding combinations with cough suppressants
Marketing authorisation? PL 00063/0760
Codes? GTIN 5011417566770 · BNF 03090200

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 11.2.0 of 16 November 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.